Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis

N Garg, P Krishan, A Syngle - Clinical rheumatology, 2015 - Springer
Enhanced cardiovascular risk in ankylosing spondylitis (AS) provides a strong rationale for
early therapeutical intervention. In view of the proven benefit of statins in atherosclerotic …

Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis

N Garg, P Krishan, A Syngle - 2015 - pubmed.ncbi.nlm.nih.gov
Enhanced cardiovascular risk in ankylosing spondylitis (AS) provides a strong rationale for
early therapeutical intervention. In view of the proven benefit of statins in atherosclerotic …

Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.

N Garg, P Krishan, A Syngle - Clinical Rheumatology, 2015 - search.ebscohost.com
Enhanced cardiovascular risk in ankylosing spondylitis (AS) provides a strong rationale for
early therapeutical intervention. In view of the proven benefit of statins in atherosclerotic …

Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis

N Garg, P Krishan, A Syngle - Clinical Rheumatology, 2015 - infona.pl
Enhanced cardiovascular risk in ankylosing spondylitis (AS) provides a strong rationale for
early therapeutical intervention. In view of the proven benefit of statins in atherosclerotic …

Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis

N Garg, P Krishan, A Syngle - Clinical Rheumatology, 2015 - search.proquest.com
Enhanced cardiovascular risk in ankylosing spondylitis (AS) provides a strong rationale for
early therapeutical intervention. In view of the proven benefit of statins in atherosclerotic …

Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.

N Garg, P Krishan, A Syngle - Clinical Rheumatology, 2015 - europepmc.org
Enhanced cardiovascular risk in ankylosing spondylitis (AS) provides a strong rationale for
early therapeutical intervention. In view of the proven benefit of statins in atherosclerotic …